Senderowicz Adrian plan to sell securities of PUMA BIOTECHNOLOGY, INC. under Form 144

Senderowicz Adrian filed Form 144 to notify SEC of plan to sell 27000 units of PUMA BIOTECHNOLOGY, INC. securities around 2026-06-12, with aggregate market value of $196,020.00. The total outstanding units is 50899456.0. The amount planned to be sold represents 0.05% of total outstanding units;